cancercalc @cancer_calc

We provide clinical tools and calculators for oncology professionals. cancercalc.com London, England Joined December 2021

Tweets

54
Followers

756
Following

5K
Likes

856

cancercalc @cancer_calc

a year ago

NEW TOOL: Immunotherapy toxicity management guidelines cancercalc.com/immunotherapy_… Summarises management of immunotherapy (ICI) toxicities according to latest society guidelines

0 1 3 507 3

Download Image

cancercalc @cancer_calc

2 years ago

Looking forward to seeing latest updates at the ESMO conference next week @myESMO #HealthTech

0 0 1 299 0

The ESMO-MCBS (Magnitude of Clinical Benefit Scale) assesses the relative value of a new cancer therapy within a reproducible scale incorporating clinical benefit, toxicity and cost. We have developed an easy to use to tool to assess the ESMO-MCBS. Link: cancercalc.com/esmo-mcbs.php

0 0 0 287 0

cancercalc @cancer_calc

2 years ago

We have updated the Manchester score based on user feedback. The score is used to predict the chance of finding a pathogenic germline BRCA 1/2 mutation. cancercalc.com/manchester.html

0 0 0 250 0

cancercalc @cancer_calc

2 years ago

Risk assessment is crucial in identifying patients at risk of Tumor Lysis Syndrome (TLS). We have developed a risk assessment tool based on the guidelines of Cairo et al. Link: cancercalc.com/tls_risk_asses… #TLS #hematooncology #rasburicase #tumorlysis

1 0 4 628 0

Download Image

cancercalc @cancer_calc

2 years ago

The IPI, R-IPI and NCCN-IPI scores predict survival in DLBCL and guide treatment. We made a convenient tool to assess these score. Link: cancercalc.com/ipi_score_dlbc… #DLBCL #IPI #NHL #Lymphoma

0 0 1 386 0

Download Image

Emil Lou, MD, PhD, FACP @cancerassassin1

2 years ago

Rise of the (#Oncology) Machines? Editorial in ⁦@TheLancetOncol⁩, just in time to stir up some debate at #ASCO23: ‘Can artificial intelligence improve cancer care?’ #deeplearning #artificialintelligence #AI thelancet.com/journals/lanon…

0 3 7 908 0

cancercalc @cancer_calc

2 years ago

We are looking forward to hearing all the latest cancer research at #ASCO23 #digitalhealth #cancercalc #cancercalculators #oncology

1 0 1 211 0

cancercalc @cancer_calc

2 years ago

The Hasenclever International Prognostic score (IPS) risk stratifies patients with advanced stage Hodgkin’s lymphoma into 6 prognostic groups. Check out our tool: cancercalc.com/hasenclever_ip… #hodgkins #hematooncology #IPS #lymphoma

0 0 0 274 0

Download Image

cancercalc @cancer_calc

2 years ago

Risk stratification of early stage classical Hodgkin’s lymphoma informs treatment strategy. We have created risk stratification calculator based on the EORTC, GHSG and NCCN criteria. Check it out. cancercalc.com/hodgkin_early_… #hodgkins #hematology

0 0 1 343 0

Download Image

cancercalc @cancer_calc

2 years ago

Individuals with DPYD (DPD) variants can experience severe toxicity to fluoropyrimidine chemo. CPIC guidelines provide genotype guided dosing recommendations. We created a DPYD calculator based on latest guidelines. Link: cancercalc.com/dpyd_score.php #DPD #dpyd #capecitabine #5FU

0 1 11 2K 3

Download Image

cancercalc @cancer_calc

2 years ago

We have updated our anthracycline cardio-toxicity dose conversion calculator based on recent literature review. Check it out below. Link: cancercalc.com/anthracycline.… #cardiooncology #anthracycline

0 9 25 3K 5

Download Image

cancercalc @cancer_calc

2 years ago

The HFA-ICOS cardio-oncology risk assessment tools stratify risk of cardiovascular complications in patients commencing cardio-toxic anti-cancer therapy. We have created an online calculator to do this. Check it out below. Link: cancercalc.com/hfa-icos_cardi… #cardio-oncology

0 4 4 1K 1

Download Image

cancercalc @cancer_calc

3 years ago

We have released a GIST recurrence risk calculator based on the Miettinen and Modified NIH classifications. Link: cancercalc.com/gist_risk.php

0 0 0 354 0

Download Image

BMJ Oncology @BMJOncology

3 years ago

What better time to launch a new journal? 🎉 Welcome to BMJ Oncology - we will capture the breadth of translational medicine, clinical endeavour, policy and opinion across the whole specialty. bmjoncology.bmj.com/content/1/1/e0… @PharmKristoffer @achoud72

3 13 49 20K 1

cancercalc @cancer_calc

3 years ago

The DCTAQ (Daily Chemotherapy Toxicity self-Assessment Questionnaire) is a tool for self-assessment of chemotherapy toxicity. It was validated in a clinical trial as an easy to use tool for toxicity monitoring. Link: cancercalc.com/DCTAQ_chemothe… #PROM #chemotherapy #QoL #ePRO

0 0 1 305 0

cancercalc @cancer_calc

3 years ago

ICANS is a serious neurotoxicity syndrome associated with cellular immune therapies. The ASTCT ICANS grading provides a system to assess severity. Check out our ICANS grade calculator: 👇 Link: cancercalc.com/ICANS_grade.php #oncology #immunotherapy #CART #IO #CART #ICANS

0 1 2 618 0

cancercalc @cancer_calc

3 years ago

Cytokine Release Syndrome (CRS) is a serious toxicity of immune therapies e.g. CAR-T therapy. The ASTCT CRS grading provides a consensus system to assess severity. Check our tool below. 👇 Link: cancercalc.com/CRS_grading.php #oncology #immunotherapy #CART #tocilizumab

0 1 2 522 0

cancercalc @cancer_calc

3 years ago

Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study ascopubs.org/doi/full/10.12…

0 0 3 869 1

cancercalc @cancer_calc

3 years ago

The RECIST 1.1 criteria are a widely used method of assessing radiological response to cancer treatment. Our RECIST calculator is an easy to use tool for tumour response assessment. Link: cancercalc.com/RECIST_1.1.php